Medtronic Infusion
Medtronic Infuse Clinical Trials Under Fire
Medtronic Infuse Adverse Events. The Side Effect Associated With Medtronic Infuse Bone Graft Product Serious questions were raised about side effects associated with Medtronic Inc.'s Infuse bone graft product by a study published in The Spine Journal last summer. The study found that published reports for 13 Medtronic-fund … [Read more...] about Medtronic Infuse Clinical Trials Under Fire
Louisiana Man Files Medtronic Infuse Lawsuit
Medtronic Infuse May Cause Unwanted Bone Growth In The Spine. The lawsuit, filed in U.S. District Court for the Eastern District of Louisiana, alleges the use of Infuse in a transforaminal lumber interbody fusion resulted in painful, unwanted bone growth along the plaintiff's spine. As we've reported previously, it's … [Read more...] about Louisiana Man Files Medtronic Infuse Lawsuit
Medtronic Infuse Worries
Cancer Risks Associated with Medtronic Infuse Bone Growth A study presented this past November raised serious concerns about cancer risks that could be associated with Medtronic Inc.'s Infuse Bone Growth product. The study was conducted by long-time Infuse critic, Dr. Eugene Carragee, and found that within a year of … [Read more...] about Medtronic Infuse Worries
Medtronic Investors to Settle Infuse Lawsuit
Medtronic Agreed To Settle A Class Action Lawsuit. Without admitting any wrongdoing, Medtronic Inc. has agreed to settle a shareholder lawsuit alleging the company made false and misleading statements about its Infuse Bone Graft product. According to a report from Bloomberg News, Medtronic will pay $85 million to settle the Infuse … [Read more...] about Medtronic Investors to Settle Infuse Lawsuit
Medtronic Infuse Woes Spawn Shareholder Infuse
Medtronic Infuse Lawsuit Due To Off-Label Use. Medtronic was hit this week with another shareholder lawsuit alleging the company illegally promoted off-label use of its Infuse bone growth product. This lawsuit alleges that because of false statements Medtronic and its officers made regarding Infuse, the company's stock … [Read more...] about Medtronic Infuse Woes Spawn Shareholder Infuse
Medtronic Infuse Controversy
Medtronic Infuse Controversy. With Medtronic Inc's sales of its Infuse bone growth product taking a hit thanks to recent controversies surrounding its possible side effects, several companies could find new markets for their spinal fusion products, according to a report from MedCity News. As we've reported previously, Medtronic is … [Read more...] about Medtronic Infuse Controversy
Dim Future for Medtronic Infuse
Cancer and Other Side Effects of Medtronic Infuse. Medtronic Inc.'s sales of its Infuse (rhBMP-2) product have taken a hit in recent months, thanks to concerns that the bone growth protein may be associated with cancer and other serious side effects. Now one analyst is raising doubts as to whether Medtronic can salvage … [Read more...] about Dim Future for Medtronic Infuse
Medtronic Infuse Shareholder Class Action Lawsuit Certified
Medtronic Infuse Class Action Lawsuit. Medtronic, Inc. got more bad news on the Infuse front yesterday, when a federal judge granted class action status to an investor shareholder lawsuit alleging the company illegally promoted off-label use of the controversial bone growth protein, causing stockholders financial … [Read more...] about Medtronic Infuse Shareholder Class Action Lawsuit Certified
FDA Announces Class 1 Recall Baxter Infusion Pumps
Class 1 Recall Baxter Infusion Pumps. The U.S. Food and Drug Administration (FDA) and Baxter Healthcare Corporation have notified healthcare professionals regarding the class 1 recall of all models of Colleague and Colleague CX volumetric infusion pumps. The electronic devices are subject to multiple malfunctions that can delay or … [Read more...] about FDA Announces Class 1 Recall Baxter Infusion Pumps
